Akebia Therapeutics (AKBA) Interest & Investment Income (2017 - 2025)
Historic Interest & Investment Income for Akebia Therapeutics (AKBA) over the last 9 years, with Q3 2025 value amounting to -$4.7 million.
- Akebia Therapeutics' Interest & Investment Income rose 2871.94% to -$4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$26.2 million, marking a year-over-year decrease of 10610.56%. This contributed to the annual value of -$18.2 million for FY2024, which is 20147.55% down from last year.
- As of Q3 2025, Akebia Therapeutics' Interest & Investment Income stood at -$4.7 million, which was up 2871.94% from -$6.8 million recorded in Q2 2025.
- Over the past 5 years, Akebia Therapeutics' Interest & Investment Income peaked at -$1.4 million during Q3 2023, and registered a low of -$7.8 million during Q1 2025.
- For the 5-year period, Akebia Therapeutics' Interest & Investment Income averaged around -$4.2 million, with its median value being -$4.8 million (2021).
- As far as peak fluctuations go, Akebia Therapeutics' Interest & Investment Income soared by 6916.24% in 2023, and later crashed by 38497.88% in 2024.
- Quarter analysis of 5 years shows Akebia Therapeutics' Interest & Investment Income stood at -$5.1 million in 2021, then skyrocketed by 67.81% to -$1.6 million in 2022, then increased by 13.33% to -$1.4 million in 2023, then crashed by 384.98% to -$6.9 million in 2024, then surged by 30.96% to -$4.7 million in 2025.
- Its Interest & Investment Income was -$4.7 million in Q3 2025, compared to -$6.8 million in Q2 2025 and -$7.8 million in Q1 2025.